[1] Alberti K, Eckel R H, Grundy S M, et al. Harmonizing the metabolic syndrome:a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity[J]. Circulation, 2009, 120(16):1640-1645. [2] Ong G, Davis W A, Davis T M. Serum uric acid does not predict cardiovascular or all-cause mortality in type 2 diabetes:the Fremantle Diabetes Study[J]. Diabetologia,2010, 53(7):1288-1294. [3] 张永媛. 基于队列设计纵向监测与概率图模型的非酒精性脂肪肝与代谢综合征双向因果推断研究[D].济南:山东大学,2013. [4] Fernández-Bergés D, Consuegra-Sánchez L, Peñafiel J, et al. Metabolic and inflammatory profiles of biomarkers in obesity, metabolic syndrome, and diabetes in a mediterranean population. DARIOS Inflammatory Study[J]. Rev Esp Cardiol (Engl Ed), 2014, 67(8):624-631. [5] Karbek B, Bozkurt N C, Topaloglu O, et al. Relationship of vaspin and apelin levels with insulin resistance and atherosclerosis in metabolic syndrome[J]. Minerva Endocrinol, 2014, 39(2):99-105. [6] Mottillo S, Filion K B, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis[J]. J Am Coll Cardiol, 2010, 56(14):1113-1132. [7] Singh A K, Kari J A. Metabolic syndrome and chronic kidney disease[J]. Current opinion in nephrology and hypertension, 2013, 22(2):198-203. [8] Lasselin J, Capuron L. Chronic low-grade inflammation in metabolic disorders:relevance for behavioral symptoms[J]. Neuroimmunomodulation, 2014, 21(2-3):95-101. [9] 段力园, 刘晨曦,赵静,等. 胰岛素抵抗状态下脂代谢和炎性反应相互关系研究进展[J]. 解放军医药杂志,2014,26(9):101-106. [10] 李娟, 郭广亚,周莉.某社区居民代谢综合征影响因素分析[J]. 中国煤炭工业医学杂志,2014,17(12):2018-2020. [11] Barazzoni R, Gortan Cappellari G G, Semolic A, et al. The association between hematological parameters and insulin resistance is modified by body mass index-results from the North-East Italy MoMa population study[J]. PLoS One, 2014, 9(7):e101590. [12] Vuong J, Qiu Y, La M, et al. Reference intervals of complete blood count constituents are highly correlated to waist circumference:Should obese patients have their own "normal values?"[J]. Am J Hematol, 2014,89(7):671-677. [13] Odagiri K, Uehara A, Mizuta I, et al. Longitudinal study on white blood cell count and the incidence of metabolic syndrome[J]. Intern Med,2011, 50(21):2491-2498. [14] Babio N, Ibarrola-Jurado N, Bulló M, et al. White blood cell counts as risk markers of developing metabolic syndrome and its components in the PREDIMED study[J]. PLoS One, 2013, 8(3):e58354. [15] Mardi T, Toker S, Melamed S, et al. Increased erythropoiesis and subclinical inflammation as part of the metabolic syndrome[J]. Diabetes Res Clin Pract,2005, 69(3):249-255. [16] Kim J A, Choi Y S, Hong J I, et al. Association of metabolic syndrome with white blood cell subtype and red blood cells[J]. Endocr J,2006, 53(1):133-139. [17] Kotani K, Sakane N, Kurozawa Y. Increased red blood cells in patients with metabolic syndrome[J]. Endocr J,2006, 53(5):711-712. [18] Lohsoonthorn V, Jiamjarasrungsi W, Williams M A. Association of hematological parameters with clustered components of metabolic syndrome among professional and office workers in bangkok, thailand[J]. Diabetes & Metab Syndr, 2007, 1(3):143-149. [19] Kawamoto R, Tabara Y, Kohara K, et al. Hematological parameters are associated with metabolic syndrome in Japanese community-dwelling persons[J]. Endocrine, 2013, 43(2):334-341. [20] Sugimori H, Tomoda F, Koike T, et al. Blood rheology and platelet function in untreated early-stage essential hypertensives complicated with metabolic syndrome[J]. Int J Hyperten, 2012, 2012:109830. [21] Phillips AC, Carroll D, Gale CR, et al. Lymphocyte sub-population cell counts are associated with the metabolic syndrome and its components in the Vietnam Experience Study. Atherosclerosis 2010, 213(1):294-298. |